US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anti-Pandemic Concept

1,433.74

+0.70560.05%

Number of Gainers:6

Number of Losers:14

Number of Flat:- -

PE:- -

High:1,446.92

Open:1,432.73

Low:1,431.35

Close:1,433.04

Loading ...

Ocugen Q4 Profit From Operations USD -13.84 Million

THOMSON REUTERS

Ocugen Q4 Net Income USD -13.88 Million

THOMSON REUTERS

Ocugen Inc: Ocu400 Remains on Track to Meet 1H 2025 Recruitment Completion and Potential Bla/Maa Filings by Mid-2026

THOMSON REUTERS

Ocugen Provides Business Update with Fourth Quarter and Full Year 2024 Financial Results

Bank of America Securities Remains a Buy on Gilead Sciences (GILD)

3 Ultra-Cheap Dividend Stocks to Buy Right Now

Moderna Shares Rise 6.3% Premarket After CEO Stephane Bancel Buys Company's Shares

THOMSON REUTERS

Positive Outlook for Evonik: Buy Rating Supported by Strong FY-25 Guidance and Cost Savings

Bayer’s Financial Challenges and Mixed Divisional Performance Lead to Hold Rating

Moderna CEO Stephane Bancel Purchases $5 Million In Company Stock

THOMSON REUTERS

APT Medical Gets Registration Certificate for Vena Cava Filter System

MT Newswires Live

Johnson & Johnson (JNJ): Among Best Stocks To Invest In From Conservative Stock Portfolio

Healthcare Stocks Fall, Led Lower by Suppliers - Healthcare Roundup

FDA Places Hold on BioNTech’s Malaria Vaccine Trial

Moderna CEO Stephane Bancel Reports Open Market Purchase of 102,821 Shares of Common Stock at Avg Price of 31.04/Share on March 3 - SEC Filing

THOMSON REUTERS

BioNTech - FDA Placed Clinical Hold On Ind Application & Related Phase I/IIA Clinical Trial (Nct06069544)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.tigerhkgo.com/stock/BK4568/news?page=13"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4568"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1433.7432,"timestamp":1741895999999,"preClose":1433.0376,"halted":0,"volume":84747908,"delay":0,"changeRate":0.000492,"change":0.705566,"pbRate":3.970758,"amount":4781935603.575559,"amplitude":0.010866,"prevYearClose":1274.8187,"fiveDayClose":1467.1393,"twentyDayClose":1380.7908,"turnoverRate":0.00548,"marketCap":1181096359413.5,"floatMarketCap":1161119145403,"peRate":31.708448},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1446.922,"amplitude":0.010866,"preClose":1433.0376,"low":1431.3503,"pbRate":"3.970758","latestPrice":1433.7432,"volume":84747908,"delay":0,"open":1432.7316,"prevYearClose":1274.8187,"prevWeekClose":1480.0557,"prevMonthClose":1463.5875,"prevQuarterClose":1274.8187,"fiveDayClose":1467.1393,"twentyDayClose":1380.7908,"sixtyDayClose":1280.0879,"secType":"PLATE","market":"US","turnoverRate":0.00548,"peRate":31.708448,"marketCap":1181096359413.5,"floatMarketCap":1161119145403,"timestamp":1741895999999,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":6,"down":14,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:16,pageCount:13,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517991397","title":"Ocugen Q4 Profit From Operations USD -13.84 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2517991397","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517991397?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:02","pubTimestamp":1741176120,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nPLX1287E6:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","BK4139","OCGN","BK4568"],"gpt_icon":0},{"id":"2517913974","title":"Ocugen Q4 Net Income USD -13.88 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2517913974","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517913974?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:02","pubTimestamp":1741176120,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nPLX1287E6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OCGN","BK4568","BK4139","BK4563"],"gpt_icon":0},{"id":"2517091324","title":"Ocugen Inc: Ocu400 Remains on Track to Meet 1H 2025 Recruitment Completion and Potential Bla/Maa Filings by Mid-2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2517091324","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517091324?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:02","pubTimestamp":1741176120,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nPLX1287E6:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","OCGN","BK4139","BK4563"],"gpt_icon":0},{"id":"2517913794","title":"Ocugen Provides Business Update with Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2517913794","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517913794?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:02","pubTimestamp":1741176120,"startTime":"0","endTime":"0","summary":"Reached an alignment with FDA on Phase 2/3 pivotal confirmatory clinical trial for OCU410ST for Stargardt disease potentially expediting clinical development by two to three years. Positive 2-year long-term data across multiple mutations of retinitis pigmentosa  from the Phase 1/2 clinical trial of OCU400 demonstrated a durable and statistically significant  improvement in visual function  in all evaluable treated subjects at two years when compared to untreated eyes. The OCU410ST Phase 2/3 clinical trial will randomize 51 subjects, 34 of whom will receive a single, subretinal, 200-μL injection of OCU410ST at a concentration of 1.5 x 1011 vector genomes /mL in the eye with worse visual acuity, and 17 of whom will serve as untreated controls. One-year data will be utilized for the BLA filing planned for 2027. 6-month data from Phase 1 of the OCU410ST GARDian clinical trial demonstrated considerably slower lesion growth (52%) from baseline in treated eyes versus untreated fellow eyes and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ocugen-provides-business-fourth-quarter-120200309.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2106854487.HKD","LU2237438978.USD","IE00BSNM7G36.USD","LU2264538146.SGD","LU0868494708.USD","LU2023250504.SGD","LU0942090050.USD","BK4597","LU0868494617.USD","LU1917777945.USD","BK4201","BK4516","BK4588","CAT","BK4520","ATMP","IE00BD6J9T35.USD","BK4585","BK4563","BK4568","EC","BK4532","BK4139","LU1974910355.USD","BK4149","LU1988902786.USD","LU1064131342.USD","OCGN"],"gpt_icon":0},{"id":"2517991313","title":"Bank of America Securities Remains a Buy on Gilead Sciences (GILD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517991313","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517991313?lang=en_us&edition=fundamental","pubTime":"2025-03-05 19:57","pubTimestamp":1741175855,"startTime":"0","endTime":"0","summary":"In a report released today, Tim Anderson from Bank of America Securities maintained a Buy rating on Gilead Sciences (GILD – Research Report), with ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-remains-a-buy-on-gilead-sciences-gild?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-remains-a-buy-on-gilead-sciences-gild?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0648000940.SGD","LU2087621335.USD","LU1162221912.USD","LU1883839398.USD","BK4139","LU1571399168.USD","LU2089984988.USD","LU0058720904.USD","BK4550","GILD","LU1880398554.USD","BK4568","LU0130102774.USD","IE00BLSP4239.USD","LU1280957306.USD","LU1363072403.SGD","BK4504","IE00BBT3K403.USD","BK4578","LU0289739699.SGD","LU2129689605.HKD","LU1894683264.USD","LU2133065610.SGD","LU0417517546.SGD","LU0098860793.USD","LU0130103400.USD","LU1496350171.SGD","LU0256863902.USD","IE00BLSP4452.SGD","LU1201861249.SGD","LU0256863811.USD","LU0053666078.USD","LU1880398471.USD","BAC","BK4532","IE00BKVL7J92.USD","LU1791807156.HKD","BK4207","LU0320765992.SGD","LU0109394709.USD","BK4585","LU1201861165.SGD","BK4583","LU2129689431.USD","LU0208291251.USD","LU0170899867.USD","LU0971096721.USD","BK4588","LU1066051498.USD","LU1668664300.SGD"],"gpt_icon":0},{"id":"2517913218","title":"3 Ultra-Cheap Dividend Stocks to Buy Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2517913218","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517913218?lang=en_us&edition=fundamental","pubTime":"2025-03-05 19:00","pubTimestamp":1741172400,"startTime":"0","endTime":"0","summary":"Verizon, Toronto-Dominion Bank, and Pfizer all pay dividends yielding at least 4.9% at their current share prices.They have all been struggling in recent years, but in the long run, they could recover and produce strong gains for shareholders.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/03/05/3-ultra-cheap-dividend-stocks-to-buy-right-now/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["IE000M9KFDE8.USD","BK4588","SG9999011175.SGD","SG9999003800.SGD","LU1066051498.USD","SG9999001176.SGD","BK4568","BK4581","LU0170899867.USD","LU0456855351.SGD","LU1894683264.USD","LU0306806265.USD","PFE","SG9999002232.USD","BK4592","LU0306807586.USD","SG9999001176.USD","LU0289739699.SGD","LU0234572021.USD","BK4533","BK4599","SGXZ57979304.SGD","LU0122379950.USD","LU0321505868.SGD","IE0002270589.USD","BK4007","SG9999013999.USD","LU1066053197.SGD","LU0321505439.SGD","LU0868494617.USD","LU1883839398.USD","LU0225771236.USD","LU0225284248.USD","SG9999002224.SGD","BK4534","IE00BLSP4452.SGD","IE00BLSP4239.USD","IE00B19Z3B42.SGD","IE00BBT3K403.USD","LU1023059063.AUD","LU1894683348.USD","LU0058720904.USD","IE00B19Z3581.USD","BK4585","BK4550","LU0985481810.HKD","LU1057294990.SGD"],"gpt_icon":1},{"id":"2517997665","title":"Moderna Shares Rise 6.3% Premarket After CEO Stephane Bancel Buys Company's Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2517997665","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517997665?lang=en_us&edition=fundamental","pubTime":"2025-03-05 18:57","pubTimestamp":1741172224,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nL3N3PO101:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MRNA","BK4139","BK4501","BK4534","BK4551","BK4568","BK4548","BK4588","BK4532","BK4585","BK4533"],"gpt_icon":0},{"id":"2517991743","title":"Positive Outlook for Evonik: Buy Rating Supported by Strong FY-25 Guidance and Cost Savings","url":"https://stock-news.laohu8.com/highlight/detail?id=2517991743","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517991743?lang=en_us&edition=fundamental","pubTime":"2025-03-05 17:46","pubTimestamp":1741168006,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus analyst Andreas Heine has maintained their bullish stance on 0QDS stock, giving a Buy rating today. Andreas Heine has given his Buy...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/positive-outlook-for-evonik-buy-rating-supported-by-strong-fy-25-guidance-and-cost-savings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/positive-outlook-for-evonik-buy-rating-supported-by-strong-fy-25-guidance-and-cost-savings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BNTX","BK4588","BK4535","BK4551","BK4548","BK4585","BK4568"],"gpt_icon":0},{"id":"2517910829","title":"Bayer’s Financial Challenges and Mixed Divisional Performance Lead to Hold Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2517910829","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517910829?lang=en_us&edition=fundamental","pubTime":"2025-03-05 17:46","pubTimestamp":1741167991,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus analyst Andreas Heine has maintained their neutral stance on 0P6S stock, giving a Hold rating on February 25. Andreas Heine has giv...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/bayers-financial-challenges-and-mixed-divisional-performance-lead-to-hold-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/bayers-financial-challenges-and-mixed-divisional-performance-lead-to-hold-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4568","BK4551","BK4548","BNTX","BK4535","BK4585","BK4139"],"gpt_icon":0},{"id":"2517981313","title":"Moderna CEO Stephane Bancel Purchases $5 Million In Company Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2517981313","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517981313?lang=en_us&edition=fundamental","pubTime":"2025-03-05 11:59","pubTimestamp":1741147156,"startTime":"0","endTime":"0","summary":"","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nFWN3PN0O4:2","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Moderna CEO Stephane Bancel Purchases $5 Million In Company Stock","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4534","BK4585","BK4533","BK4588","BK4139","BK4551","BK4532","BK4501","BK4548","BK4568"],"gpt_icon":1},{"id":"2517913956","title":"APT Medical Gets Registration Certificate for Vena Cava Filter System","url":"https://stock-news.laohu8.com/highlight/detail?id=2517913956","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517913956?lang=en_us&edition=fundamental","pubTime":"2025-03-05 11:47","pubTimestamp":1741146469,"startTime":"0","endTime":"0","summary":"APT Medical , through a subsidiary, obtained a medical device registration certificate from the Chinese drug administration for its vena cava filter system, according to a Wednesday filing with the Shanghai Stock Exchange.The device is inserted through the femoral vein or jugular vein to prevent pulmonary embolism, the medical device company said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["APT.USD.HKCC","BK4568","BK0251","BK4086","APT","688617","APT.USD.CC"],"gpt_icon":0},{"id":"2517585939","title":"Johnson & Johnson (JNJ): Among Best Stocks To Invest In From Conservative Stock Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2517585939","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517585939?lang=en_us&edition=fundamental","pubTime":"2025-03-05 08:35","pubTimestamp":1741134943,"startTime":"0","endTime":"0","summary":"Latest reports indicate that hedge funds have been dumping the shares of technology and media companies at the fastest rate in the past six months. For those who mimic the investing strategy of hedge funds for maximum financial gains, this is cause for alarm. The dumping of tech and media firms by billionaires suggests that it is time for investors to consider pouring their money into more conservative stocks to balance portfolios against riskier growth options. These conservative stocks, also sometimes called blue-chip stocks, are well-established companies with a history of stable earnings, reliable dividends, and strong market positions. These stocks are typically less volatile, making them appealing to risk-averse investors seeking steady growth and income. However, recent developments in the global economy and political landscape may influence the performance and attractiveness of conservative stocks.Read more about these developments by accessing10 Best AI Data Center Stocksand10","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/johnson-johnson-jnj-among-best-003543788.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2129689605.HKD","IE00B3PB1722.GBP","LU0795875169.SGD","LU1674673691.USD","BK4588","LU1244550494.USD","LU1221951129.SGD","LU2129689514.USD","BK4568","BK4581","IE00BJJMRZ35.SGD","LU1261432733.SGD","SG9999001440.SGD","LU2430703095.HKD","LU0203345920.USD","LU0234572021.USD","LU0345769631.USD","LU0466842654.USD","LU1066051225.USD","LU2505996681.GBP","IE00B4R5TH58.HKD","IE0034235303.USD","LU1032466523.USD","LU1914381329.SGD","LU0122379950.USD","LU1430594728.SGD","LU1066053197.SGD","LU1244550577.SGD","IE00B7SZLL34.SGD","LU0114720955.EUR","LU1074936037.SGD","BK4534","IE00BJT1NW94.SGD","LU0203347892.USD","IE00B19Z3B42.SGD","LU2347655156.SGD","LU1023059063.AUD","LU2602419157.SGD","LU1674673428.USD","LU1894683348.USD","IE00BFTCPJ56.SGD","LU0058720904.USD","JNJ","LU1061106388.HKD","IE00B19Z3581.USD","BK4559","LU1929549753.HKD","LU2592432038.USD","IE00B2B36J28.USD","BK4550"],"gpt_icon":0},{"id":"2517984326","title":"Healthcare Stocks Fall, Led Lower by Suppliers - Healthcare Roundup","url":"https://stock-news.laohu8.com/highlight/detail?id=2517984326","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517984326?lang=en_us&edition=fundamental","pubTime":"2025-03-05 05:51","pubTimestamp":1741125060,"startTime":"0","endTime":"0","summary":"Healthcare shares' performance Tuesday hinged on their exposure to trade.Tariff news slammed healthcare companies that depend on trade. Suppliers such as Becton, Dickinson and Abbott Laboratories suffered as trade tensions darkened the picture for imports and exports.Domestic insurers and providers shook off the news. Plans like UnitedHealth Group, Elevance and Humana shook off the news to finish in the green. So did clinics like LabCorp Holdings--although kidney-care's DaVita declined.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","IE00BFTCPJ56.SGD","LU0234572021.USD","LU2237957902.USD","LU1989763690.USD","LU2089984988.USD","LU0266013472.USD","IE0002141913.USD","LU1061106388.HKD","LU2468319806.SGD","BK4568","BK4082","LU1721429741.USD","LU1914381329.SGD","LU1691799644.USD","LU1989763427.SGD","ABT","BK4504","IE00BJJMRZ35.SGD","SG9999002232.USD","LU1023059063.AUD","IE00B2B36J28.USD","LU2133065610.SGD","SG9999004303.SGD","BK4137","LU1721429402.USD","IE0009355771.USD","BK4533","LU2237957811.SGD","BK4581","LU2112291526.USD","LU0868494617.USD","LU0122379950.USD","BK4585","HCSG","IE00B4R5TH58.HKD","BK4566","SG9999002224.SGD","SGXZ23171101.USD","LU0170899867.USD","BK4588","BK4592","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2517981030","title":"FDA Places Hold on BioNTech’s Malaria Vaccine Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2517981030","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517981030?lang=en_us&edition=fundamental","pubTime":"2025-03-05 05:38","pubTimestamp":1741124335,"startTime":"0","endTime":"0","summary":"BioNTech SE ( ($BNTX) ) has issued an update. The U.S. Food and Drug Administration (FDA) has placed a clinical hold on BioNTech SE’s Investigation...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fda-places-hold-on-biontechs-malaria-vaccine-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fda-places-hold-on-biontechs-malaria-vaccine-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BNTX","BK4568","BK4588","BK4548","BK4535","BK4139","BK4551"],"gpt_icon":0},{"id":"2517981392","title":"Moderna CEO Stephane Bancel Reports Open Market Purchase of 102,821 Shares of Common Stock at Avg Price of 31.04/Share on March 3 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2517981392","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517981392?lang=en_us&edition=fundamental","pubTime":"2025-03-05 05:30","pubTimestamp":1741123817,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nFWN3PN0O4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4501","BK4532","BK4533","BK4548","BK4585","BK4534","BK4139","BK4588","MRNA","BK4568","BK4551"],"gpt_icon":0},{"id":"2517764989","title":"BioNTech - FDA Placed Clinical Hold On Ind Application & Related Phase I/IIA Clinical Trial (Nct06069544)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517764989","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517764989?lang=en_us&edition=fundamental","pubTime":"2025-03-05 05:24","pubTimestamp":1741123460,"startTime":"0","endTime":"0","summary":"March 4 (Reuters) - BioNTech SE <22UAy.DE>::*BIONTECH- FDA PLACED CLINICAL HOLD ON IND APPLICATION & RELATED PHASE I/IIA CLINICAL TRIAL (NCT06069544) EVALUATING SAFETY,EFFICACY OF BNT165E*BIONTECH SE ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nRSDbhmN94:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTX","BK4139","BK4568","BK4585","BK4551","BK4588","BK4548","BK4535"],"gpt_icon":0}],"pageSize":16,"totalPage":19,"pageCount":13,"totalSize":302}]}}